MLTX
#2440
MoonLake Immunotherapeutics - Class A Ordinary Shares
10.6 8 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.29%
Variación mensual
-14.97%
Variación en los últimos 6 meses
-43.04%
Cambio anual
+11.72%
Cierres anteriores
10.8 2
Open
10.8 2
Mínimo
10.6 6
Máximo
10.9 5
Financials
- Market Capitalization 908.94 M
- Employee 130
- Founded 2020
- CEO N/A
- Website www.moonlaketx.com
- Headquarter Cayman Islands
- FIGI BBG00XQZQTS9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.73
Relación precio/flujo de caja
1 418.42
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2434 |  ALMS Alumis Inc. - Common Stock | 7.06 USD | -1.40% | +2.47% | -23.68% | +56.54% | 913.81 M USD | ||
| 2436 |  RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 48.81 USD | -0.55% | +1.31% | +3.15% | +62.00% | 911.76 M USD | ||
| 2456 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 10.52 USD | +2.14% | +1.35% | -26.69% | -6.90% | 897.50 M USD | ||
| 2463 |  JBIO Jade Biosciences, Inc. - Common Stock | 14.00 USD | -2.71% | +2.49% | -22.48% | +39.30% | 890.36 M USD |